Saturday, December 8 - Scientific Presentations

OncoLink Booth 264 at ASH 2001.

Analysis of Predisposing Factors for Hepatic Veno-Occlusive Disease after Treatment with Gemtuzumab Ozogamicin (Mylotargr, CMA-676).
Candidate Gene Targets of the c-Myb Protooncogene in Human Myloid Leukemia
Inter-Institutional Second Opinion Pathologic Review of Lymphoproliferative Disorders After WHO Classification.
Low Penetration of Imatinib (STI571) into the CSF Indicates the Need for Standard CSF Prophylaxis in Patients with CML Lymphoid Blast Crisis and Philadelphia Chromosome Positive ALL
Novel Erythropoeisis Stimulating Protein (Aranesp) Enhances Pegylated Soluble Tumor Necrosis Factor Receptor Type 1 (PEG sTNF-R1) Alleviation of Anemia of Chronic Disease (ACD) in a Rodent Model of Systemic Inflammation.
Positron Emission Tomography with 18F-FDG in the Evaluation of Post-Treatment Residual Mass in Patients with Malignant Lymphoma.
STI-571 in the Treatment of Children with Philadelphia (Ph+) Chromosome-Positive Leukemia: Results from a Children's Oncology Group (COG) Phase I Study.
Study of Bone Marrow Involvement in 1161 Consecutive Hodgkin's Lymphoma Patients.
Utility of 18-FDG-PET Scanning in Lymphoma by WHO Classification